Literature DB >> 35753845

Toll-like receptor-mediated neuroinflammation: relevance for cognitive dysfunctions.

Silvia Squillace1, Daniela Salvemini2.   

Abstract

Toll-like receptors (TLRs) are pattern recognition receptors (PRRs) with a well-documented role in the innate and adaptive immune responses. Interestingly, TLR activation has also been linked to several brain functions including neurogenesis and synaptogenesis. Increasing evidence supports TLR involvement in peripheral and central inflammation underlying normal aging and the pathogenesis of clinical conditions characterized by cognitive decline. These include not only major neurodegenerative diseases but also traumatic brain injuries, surgeries, and alcohol consumption- and chemotherapy-induced cognitive impairment. We first summarize the physiological roles of TLRs in the nervous system, and then illustrate the emerging involvement of TLRs in cognitive functions, pointing to these receptors as novel enticing pharmacological targets to develop more efficient drugs for the treatment of cognitive impairment.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Toll-like receptors; cognitive functions; glia; gut–brain axis; neuroinflammation

Mesh:

Substances:

Year:  2022        PMID: 35753845      PMCID: PMC9378500          DOI: 10.1016/j.tips.2022.05.004

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   17.638


  109 in total

1.  Toll-like receptor 3 activation increases voluntary alcohol intake in C57BL/6J male mice.

Authors:  Anna S Warden; Moatasem Azzam; Adriana DaCosta; Sonia Mason; Yuri A Blednov; Robert O Messing; R Dayne Mayfield; R Adron Harris
Journal:  Brain Behav Immun       Date:  2018-12-11       Impact factor: 7.217

Review 2.  Enteric glial biology, intercellular signalling and roles in gastrointestinal disease.

Authors:  Luisa Seguella; Brian D Gulbransen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-03-17       Impact factor: 46.802

Review 3.  DAMPs, ageing, and cancer: The 'DAMP Hypothesis'.

Authors:  Jin Huang; Yangchun Xie; Xiaofang Sun; Herbert J Zeh; Rui Kang; Michael T Lotze; Daolin Tang
Journal:  Ageing Res Rev       Date:  2014-10-30       Impact factor: 10.895

4.  Cognitive impairment in Crohn's disease is associated with systemic inflammation, symptom burden and sleep disturbance.

Authors:  Daniel R van Langenberg; Greg W Yelland; Stephen R Robinson; Peter R Gibson
Journal:  United European Gastroenterol J       Date:  2016-08-08       Impact factor: 4.623

5.  Toll-Like Receptor 5 Promotes the Neurogenesis From Embryonic Stem Cells and Adult Hippocampal Neural Stem Cells in Mice.

Authors:  Kyung-Joo Seong; Seungho Choi; Hyun-Gwan Lee; Joon Haeng Rhee; Jin Ho Lee; Jeong-Tae Koh; Sun-Hun Kim; Won-Seok Choi; Ji-Yeon Jung; Won-Jae Kim
Journal:  Stem Cells       Date:  2022-03-31       Impact factor: 6.277

6.  Toll-like receptor 4 deficiency facilitates α-synuclein propagation and neurodegeneration in a mouse model of prodromal Parkinson's disease.

Authors:  Serena Venezia; Walter A Kaufmann; Gregor K Wenning; Nadia Stefanova
Journal:  Parkinsonism Relat Disord       Date:  2021-09-11       Impact factor: 4.891

7.  Toll-like receptor 4 deficiency ameliorates β2-microglobulin induced age-related cognition decline due to neuroinflammation in mice.

Authors:  Qi Zhong; Yufeng Zou; Hongchao Liu; Ting Chen; Feng Zheng; Yifei Huang; Chang Chen; Zongze Zhang
Journal:  Mol Brain       Date:  2020-02-14       Impact factor: 4.041

Review 8.  TLR4 Targeting as a Promising Therapeutic Strategy for Alzheimer Disease Treatment.

Authors:  Yongji Zhou; Yanxing Chen; Congcong Xu; Hao Zhang; Caixiu Lin
Journal:  Front Neurosci       Date:  2020-12-18       Impact factor: 4.677

9.  Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation.

Authors:  Henrieta Scholtzova; Peter Chianchiano; Jason Pan; Yanjie Sun; Fernando Goñi; Pankaj D Mehta; Thomas Wisniewski
Journal:  Acta Neuropathol Commun       Date:  2014-09-02       Impact factor: 7.801

Review 10.  Recent clinical trends in Toll-like receptor targeting therapeutics.

Authors:  Muhammad Ayaz Anwar; Masaud Shah; Jason Kim; Sangdun Choi
Journal:  Med Res Rev       Date:  2018-11-18       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.